Compare Neurocrine Biosciences Inc (NBIX) vs Skyworks Solutions Inc (SWKS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Neurocrine Biosciences Inc vs Skyworks Solutions Inc — how do they compare? Neurocrine Biosciences Inc trades at $179.88 (market cap $17.40B), while Skyworks Solutions Inc trades at $62.81 (market cap $8.99B). The key difference: Neurocrine Biosciences Inc is the larger of the two by market cap, and Skyworks Solutions Inc pays a 4.75% dividend while Neurocrine Biosciences Inc pays none. Which is the better fit depends on your goals.
| NBIX | SWKS | |
|---|---|---|
Market Cap | $17.40B | $8.99B |
Sector | Health | Technology |
52-Week High | $180.55 | $83.40 |
52-Week Low | $123.10 | $52.50 |
Enterprise Value | $16.49B | $8.76B |
Dividend Yield | — | 4.75% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Neurocrine Biosciences Inc
Neurocrine Biosciences, Inc. is a biopharmaceutical company focused on discovering, developing, and commercializing innovative treatments for neurological, endocrine, and psychiatric disorders. The company's portfolio targets conditions such as tardive dyskinesia, endometriosis, and Parkinson's disease. NBIX leverages its expertise in neurobiology and small-molecule drug development to address diseases with significant unmet medical needs.
Read more on NBIX →About Skyworks Solutions Inc
Skyworks Solutions produces semiconductors for wireless handsets and other devices that are used to enable wireless connectivity. Its main products include power amplifiers, filters, switches, and integrated front-end modules that support wireless transmissions. Skyworks' customers are mostly large smartphone manufacturers, but the firm also has a growing presence in nonhandset applications such as wireless routers, medical devices, and automobiles.
Read more on SWKS →
